Yeah. I think Terry is absolutely right. And the two segments that I would just hone in on, Benjamin, that we saw particularly double-digit growth from last year was really the buy side and the commodities, or sorry, the commercial segment as well. And so when we look at that, we saw really strong ADV from asset managers, again, double-digit, the [semi-buy] (ph) side clients that really are looking at our products because of the regulatory environment, the liquidity, and also the capital efficiencies that we offer. And so the products that I'd say they were most interested in and what we saw, almost half of that growth was coming from interest rates with all of the volatility and movement that we saw last year, but also a lot of interest in our commodity suite. So hedge funds, managed funds that are really looking at CME's agricultural portfolio, and also more esoteric products, things that we offer like milk and lumber, because they're looking to diversify the risk profiles and also access those uncorrelated markets. And so it's another sign of our really diverse product portfolio, meeting customer needs. On the commercial side, double-digit growth, both in terms of revenue and ADV last year. And that was really as they were looking to hedge their physical positions, manage that risk exposure, saw good uptake in some of our new industrial metals, the energy companies that we talked about before. And I think this trend speaks to the transparency, the efficiencies, and the well-regulated futures markets that we offer. And then internationally, I think, particularly in Europe, on the short-term interest rate side, we saw some really strong performance and also interest across our commodities and FX suite. So I think we have a lot to build on as we look into 2024, but very strong performance in those areas last year.